GRI BIO INC (GRI) Stock Income Statement
NASDAQ:GRI - Nasdaq - US3622AW4030 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K | |||
| Operating Expenses | 9.39M | 11.39M | 6.93M | 9.26M | 4.89M | |||
| Research and Development | 4.48M | 3.23M | 1.17M | 5.19M | 3.71M | |||
| Selling, General, and Administrative Expenses | 4.92M | 8.15M | 5.76M | 4.07M | 1.18M | |||
| Operating Income | -9.39M | -11.39M | -6.93M | -9.26M | -4.79M | |||
| Interest Income/Expense | 24.00K | -1.90M | 410.00K | -105.00K | -34.00K | |||
| Other Income/Expense | 1.00K | 250.00K | -506.00K | 61.00K | N/A | |||
| Non Recurring Items | N/A | 0.00 | N/A | N/A | N/A | |||
| Income Before Taxes | -9.37M | -13.04M | -7.02M | -9.30M | -4.82M | |||
| Net Income | -11.28M | -13.04M | -7.02M | -9.30M | -4.82M | |||
| EBITDA | -9.39M | -11.38M | -6.72M | -9.17M | -4.71M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -108.64 | -6.24K | -31.93K | -62.02K | -32.15K | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | -4822.00% | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | -4788.00% | |||
All data in USD